Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Revelation Biosciences Inc (REVB)

Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Revelation Biosciences Expands Acute Kidney Injury Advisory Board ACCESS Newswire - Mon Jun 1, 4:00AM CDT

SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat...

REVB : 0.9900 (-6.16%)
Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders ACCESS Newswire - Mon May 11, 4:00AM CDT

SAN DIEGO, CA / ACCESS Newswire / May 11, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat...

REVB : 0.9900 (-6.16%)
Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026 ACCESS Newswire - Thu May 7, 11:15AM CDT

SAN DIEGO, CA / ACCESS Newswire / May 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat...

REVB : 0.9900 (-6.16%)
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board ACCESS Newswire - Mon Apr 6, 4:00AM CDT

SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat...

REVB : 0.9900 (-6.16%)
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study ACCESS Newswire - Mon Mar 30, 4:00AM CDT

- A majority of CKD patients present with cellular inflammation and immunoparalysis predose -

REVB : 0.9900 (-6.16%)
REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference ACCESS Newswire - Tue Mar 24, 4:00AM CDT

SAN DIEGO, CA / ACCESS Newswire / March 24, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation...

REVB : 0.9900 (-6.16%)
Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference ACCESS Newswire - Thu Mar 19, 4:00AM CDT

SAN DIEGO, CA / ACCESS Newswire / March 19, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation...

REVB : 0.9900 (-6.16%)
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025 ACCESS Newswire - Thu Feb 26, 10:15AM CST

SAN DIEGO, CA / ACCESS Newswire / February 26, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation...

REVB : 0.9900 (-6.16%)
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026 ACCESS Newswire - Mon Jan 26, 3:55AM CST

SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 26, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), announced today that, on January 28, 2026, the Company will implement...

REVB : 0.9900 (-6.16%)
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds ACCESS Newswire - Fri Jan 23, 8:10AM CST

SAN DIEGO, CA / ACCESS Newswire / January 23, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation,...

REVB : 0.9900 (-6.16%)

Barchart Exclusives

Tesla Sales in China Are Popping, But That Means Nothing If You Can’t Stomach TSLA Stock’s Absurd P/E Ratio Barchart - Sat Jun 6, 3:00PM CDT
Tesla China sales jumped almost 40% in May as its FSD software rolled out globally. Here's why TSLA stock still belongs on your watch list now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.